drugset / Trial / NCT00641147

Curcumin in Treating Patients With Familial Adenomatous Polyposis

NCT00641147

Phase 2 Completed 44 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupDouble-blindTreatment

Summary

This randomized phase II trial studies curcumin in treating patients with familial adenomatous polyposis. Curcumin may prevent colorectal cancer in patients with a history of rectal polyps or colorectal neoplasia.

Timeline

Start
2010-10
Primary completion
2016-11
Completion
2016-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcumin Small molecule 1500 mg Oral